Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
  •  
Login | Create an Account

25th Psychiatric Pharmacotherapy Update 2013 • Social Work & Counselor CEU Registration


ICDD

The University of Texas at Austin College of Pharmacy is proud to be hosting the 25th Annual Psychiatric Pharmacotherapy Update, October 24 & 25, 2013 in Austin, Texas. 

This educational conference is presented by the College of Pharmacy's Continuing Pharmacy Education department and Psychiatric Pharmacy Program to meet the educational needs of practitioners who provide care to patients with mental health disorders.

Click here for the 25th Annual Psychiatric Pharmacotherapy Update Website

 
 

Date: Oct 24, 2013 07:00 AM - Oct 25, 2013 05:00 PM

Fee

$410.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 24, 2013 11:59 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Social Workers
  • Counselors

Requirements for CE Credit

Social Workers & Counselors
 
 
UT Social Work Logo

This training has been provided in accordance with the criteria and standards of the Texas Board of Social Work Examiners, and is approved for Social Workers by The University of Texas at Austin School of Social Work for up to 15.0 hours of Social Work CEUs.

The Professional Development Program at the University of Texas at Austin School of Social Work is a CEU provider for the following licensures.

If you are licensed outside of the state of Texas, please contact your professional licensing board to confirm reciprocity with Texas licensure.

Social Work:
LMSW (Licensed Master Social Workers)
LCSW and LMSW-AP (Advanced Practitioners) LBSW (Licensed Baccalaureate Social Workers) LPC (Licensed Professional Counselors)
LMFT (Licensed Marriage and Family Therapists)

Continuing Education Credit for Addictions Counselors: LCDC (Licensed Chemical Dependence Counselors) TAAP (Texas Association of Addiction Professionals)

Provider #1634-02 approved by the Texas Certification Board of Alcoholism and Drug Abuse Counselors. Direct complaints to TCBADAC Standards Committee, 1717 West 6th St., Ste. 214, Austin, TX, 78703 (Fax: 512-708-0635).

In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and complete the online evaluations for each session at the conclusion of the program.

Complaints about this program may be made to TSBSWE, 1100 W. 49th St., Austin, TX 78756, or 800-232-3162 or Texas State Board of Social Work Examiners website:http://www.dshs.state.tx.us/socialwork/
 
This conference is also accredited for CME, CPE, CNE, and APA credit hours.  To ensure you receive the appropirate credit, please be sure to register through your appropriate professional group.  For more information, please see the event main website at:  http://www.utexas.edu/pharmacy/ce/conferences/psych/

 

 

Thu, Oct 24, 2013
Registration closes on Oct 24, 2013 at 11:59 PM

Session I: Trends in the Use of Psychopharmacology in Children Adolescents in Texas
Registration Closed  

Speaker(s)/Author(s)

Emilie Attwell Becker, MD
Behavior Health Medical Director, Texas Department State Health Services


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/24/13
Time: 07:45 AM - 08:45 AM

CE Hours

1.00
Registration Closed  

Session II: Mental Health in the Patient Centered Medical Home
Registration Closed  

Speaker(s)/Author(s)

Tera Moore, PharmD, BCPS, BCACP
Clinical Assistant Professor, University of Texas College of Pharmacy


Disclosure : No Conflict of Interests Disclosure statements for CPE, CME, and CNE. No relevant financial relationship(s), potential or perceived with commercial or conflicts of interest to disclose.
Date: 10/24/13
Time: 08:45 AM - 09:45 AM

CE Hours

1.00
Registration Closed  

Session III: Traumatic Brian Injury Treatment Update
Registration Closed  

Speaker(s)/Author(s)

Kimberly Arlinghaus, MD picture

Kimberly Arlinghaus, MD
Medical Director of Psychiatry and Behavioral Health, Lone Star Circle of Care


Disclosure : Dr. Arlinghaus has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Date: 10/24/13
Time: 10:00 AM - 11:00 AM

CE Hours

1.00
Registration Closed  

Session IV: Psychotropic New Drug Update
Registration Closed  

Speaker(s)/Author(s)

Stephen R. Saklad, PharmD, BCPP picture

Stephen R. Saklad, PharmD, BCPP, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy


Disclosure : Financial Disclosure: consultant or advisory role with Eli Lilly and Ortho McNeil Janssen; on the speaker’s bureau for Janssen, Merck, and Novartis; investigator Ortho McNeil Janssen
Date: 10/24/13
Time: 11:00 AM - 12:00 PM

CE Hours

1.00
Registration Closed  

Session V: 25 Year Retrospective of Psychiatric Pharmcotherapy, Where We Were, and Where We are Headed
Registration Closed  

Speaker(s)/Author(s)

Larry Ereshefsky

Date: 10/24/13
Time: 12:30 PM - 01:00 PM

CE Hours

0.50
Registration Closed  

Session VI: Interprofessional Panel - Continued Discussion of 25th Year Retrospective of Psychiatric Pharmacotherapy
Registration Closed  

Speaker(s)/Author(s)

Larry Ereshefsky

Stephen R. Saklad, PharmD, BCPP picture

Stephen R. Saklad, PharmD, BCPP, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy


Disclosure : Financial Disclosure: consultant or advisory role with Eli Lilly and Ortho McNeil Janssen; on the speaker’s bureau for Janssen, Merck, and Novartis; investigator Ortho McNeil Janssen
Date: 10/24/13
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Session VII: Overview and Assessment of Drug-Induced Movement Disorders
Registration Closed  

Speaker(s)/Author(s)

Roger Sommi PharmD, BCPP, FCCP
Professor of Pharmacy Practice and Psychiatry, University of Missouri - Kansas City


Disclosure : Conflict of Interest Disclosure: Speaker/Bureau: Merck, Otuska, and Sunovion. Consultant: College of Psychiatric and Neurologic Pharmacists. Contracted Research: Bristol Myers Squibb, Eli Lilly, Merck, NIMH, Ortho-McNeil, Janssen, Otuska, Sanofi-aventis, Solvay, and Novartis.
Date: 10/24/13
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
Registration Closed  

Session VIII: Micronutrient Deficiencies: Clinical Issues and Developments
Registration Closed  

Speaker(s)/Author(s)

Thomas Brown MD
Psychiatry Consultation - Liason Services, Audi L. Murphy Memorial VAMC


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/24/13
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
Registration Closed  

Session IX: Advances in the Treatment of Alzheimer's Disease and Other Dementias
Registration Closed  

Speaker(s)/Author(s)

Larry Ereshefsky

Date: 10/24/13
Time: 04:15 PM - 05:15 PM

CE Hours

1.00
Registration Closed  

Fri, Oct 25, 2013
Registration closes on Oct 24, 2013 at 11:59 PM

Session X: Schizophrenia Update
Registration Closed  

Speaker(s)/Author(s)

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/25/13
Time: 08:15 AM - 09:15 AM

CE Hours

1.00
Registration Closed  

Session XI: Bipolar Disorder Update
Registration Closed  

Speaker(s)/Author(s)

Jana Shults PharmD, BCPP
Clinical Pharmacy Specialist - Mental Healt, South Texas Veterans Healthcare System


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/25/13
Time: 09:15 AM - 10:15 AM

CE Hours

1.00
Registration Closed  

Session XII: Depression Update: Focus on Treatment Resistant Depression and Off-Label Drug Use
Registration Closed  

Speaker(s)/Author(s)
Date: 10/25/13
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
Registration Closed  

Session XIII: Update on Street Drugs / Substance Abuse and Treatments
Registration Closed  

Speaker(s)/Author(s)

April Cope, PharmD, BCPP
Clinical Pharmacy Specialist in Behavioral Health, James E Van Zandt VA Medical Center


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/25/13
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed  

Session XIV: Interprofessional Panel - Continued Discussion of Substance Abuse and Treatments
Registration Closed  

Speaker(s)/Author(s)

April Cope, PharmD, BCPP
Clinical Pharmacy Specialist in Behavioral Health, James E Van Zandt VA Medical Center


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/25/13
Time: 01:00 PM - 01:30 PM

CE Hours

0.50
Registration Closed  

Session XV: Neurobiology Update
Registration Closed  

Speaker(s)/Author(s)

Pedro L. Delgado

Date: 10/25/13
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
Registration Closed  

Session XVI: Drug Therapy-Related Issues in Patients Who Received Bariatric Surgery
Registration Closed  

Speaker(s)/Author(s)

Lingtak-Neander Chan PharmD, BCNSP
Associate Professor Pharmacy, School of Pharmacy


Disclosure : Financial Disclosure: no relevant financial relationships to disclose
Date: 10/25/13
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
Registration Closed  



System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
  • Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
  • Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities produced by UT Continuing Pharmacy Education are intended solely to supplement health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
The University of Texas at Austin College of Pharmacy • Continuing Pharmacy Education
2409 University Ave., Stop A1904 | Austin, Texas 78712
Comments to:  UTpharmacyCE@austin.utexas.edu
College of Pharmacy, The University of Texas at Austin
 
LMS Powered By: Learning ExpressCE
Copyright © 2025 University of Texas at Austin College of Pharmacy. All Rights Reserved.
About Us Privacy Policy Terms of Service